Request for Covid-19 Impact Assessment of this Report

Take Action
Medical Devices

Global Nuclear Medicine Diagnostics Market Size study, by Type (SPECT radiopharmaceuticals, PET radiopharmaceuticals) Modality (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy) Application (Cardiology, Thyroid, Neurology, Oncology, Others) Procedure (Oncology, Cardiovascular, Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary, others) End User (Hospital and diagnostic centres, and Research institutions) and Regional Forecasts 2021-2027

  • BIZ4604540
  • 200 Pages
  • July 2021
  • Medical Devices
Download Sample    Get Discount   
 
Global Nuclear Medicine Diagnostics Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. The market is currently expanding due to an increase in the number of cancer cases and increased awareness of nuclear medicine. Radiopharmaceuticals are pharmaceutical formulations that contain radioactive isotopes for diagnostic and therapeutic purposes. They are tiny basic objects that contain a radioactive chemical that is used to treat cancer, as well as cardiac and neurological diseases. For oncology and cancer treatment, traditional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals, which opens up new paths in the radiopharmaceuticals industry. It also serves as a convenient and safer alternative to X-Rays and other external radiation imaging equipment for patients. In applications such as lymphoma and bone metastases, radiopharmaceuticals, often known as nuclear medications, are used. Nuclear medicines such as F-18, Tc-99, Ga-67, and I-123 are used in diagnostic operations, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are employed in therapeutic procedures. Thyroid-related diseases, respiratory diseases, bone diseases, and neurological diseases are among the disorders for which research and studies are undertaken. For instance, in July 2019, French researchers presented data demonstrating the use of hafnium oxide nanoparticle NBTXR3 as a radio enhancer to boost radiation response for soft-tissue sarcoma. PET is a type of radioisotope imaging that employs radioisotopes to diagnose organs. PET is becoming more widely used as a diagnostic tool because it is more accurate than other diagnostic procedures. It is usually combined with X-ray and computed tomography to improve accuracy (CT). The radiopharmaceuticals market is being fueled by a growing demand for rapid and precise diagnosis, as well as a growing demand for better medical solutions. The radiopharmaceuticals market is being fueled by a growing demand for early and precise diagnosis, as well as a demand for better medical solutions. However, radiopharmaceuticals' short half-life hinders their potential adoption, while hospital budget cuts and costly equipment expenses are projected to limit market growth.

The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Nuclear Medicine Diagnostics market. Due to high investments in R&D and government support for the use of medical isotopes, North America dominated the global market in terms of revenue in 2019. In the same year, Europe's market also accounted for a significant portion of the global market. During the forecast period, the Asia Pacific market is expected to increase at a significant rate. The radiopharmaceuticals market in this region is growing due to an increasing elderly population and increased awareness of nuclear treatments and molecular imaging. This region is also concentrating on the development of radiopharmaceuticals for the diagnosis and treatment of a variety of disorders. For instance, In August 2018, the National Nuclear Agency of Indonesia (BATAN) collaborated with the International Atomic Energy Agency (IAEA) to create innovative radiopharmaceuticals (99mTc-ethambutol) for tuberculosis diagnostics.

Major market player included in this report are:

Cardinal Health

GE Healthcare

Curium Pharma

Lantheus Medical Imaging

Bayer AG

Bracco Imaging SpA

Nordian

Advanced Accelerator Applications

IBA Molecular Imaging

Mallinckrodt PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

PET radiopharmaceuticals SPECT radiopharmaceuticals

By Modality:

SPECT

PET

Alpha-emitters

Beta-emitters

Brachytherapy

By Application:

Cardiology

Thyroid

Neurology

Oncology

Others

By Procedure:

Oncology

Cardiovascular

Central Nervous System

Endocrine

Skeletal

Gastrointestinal

Genito-urinary

Pulmonary

PET & PET-CT

Therapeutic

Others

By End-User:

Hospitals and diagnostic centers

Research Institutes

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Nuclear Medicine Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Nuclear Medicine Diagnostic Market, by Region, 2019-2027 (USD Billion)

1.2.2. Nuclear Medicine Diagnostic Market, by Type, 2019-2027 (USD Billion)

1.2.3. Nuclear Medicine Diagnostic Market, by Modality, 2019-2027 (USD Billion)

1.2.4. Nuclear Medicine Diagnostic Market, by Application, 2019-2027 (USD Billion)

1.2.5. Nuclear Medicine Diagnostic Market, by Procedure, 2019-2027 (USD Billion)

1.2.6. Nuclear Medicine Diagnostic Market, by End-User, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Nuclear Medicine Diagnostic Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Nuclear Medicine Diagnostic Market Dynamics

3.1. Nuclear Medicine Diagnostic Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Rising number of new cancer cases

3.1.1.2. Increasing adoption of SPECT and PET modality

3.1.2. Market Challenges

3.1.2.1. Stringent government regulations

3.1.3. Market Opportunities

3.1.3.1. Innovations in neurological applications

Chapter 4. Global Nuclear Medicine Diagnostic Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Nuclear Medicine Diagnostic Market, by Type

5.1. Market Snapshot

5.2. Global Nuclear Medicine Diagnostic Market by Type, Performance - Potential Analysis

5.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Type 2018-2027 (USD Billion)

5.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis

5.4.1. SPECT radiopharmaceuticals

5.4.2. PET radiopharmaceuticals

Chapter 6. Global Nuclear Medicine Diagnostic Market, by Modality

6.1. Market Snapshot

6.2. Global Nuclear Medicine Diagnostic Market by Modality, Performance - Potential Analysis

6.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Modality 2018-2027 (USD Billion)

6.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis

6.4.1. SPECT

6.4.2. PET

6.4.3. Alpha-emitters

6.4.4. Beta-emitters

6.4.5. Brachytherapy

Chapter 7. Global Nuclear Medicine Diagnostic Market, by Application

7.1. Market Snapshot

7.2. Global Nuclear Medicine Diagnostic Market by Application, Performance - Potential Analysis

7.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

7.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis

7.4.1. Cardiology

7.4.2. Thyroid

7.4.3. Neurology

7.4.4. Oncology

7.4.5. Others

Chapter 8. Global Nuclear Medicine Diagnostic Market, by Procedure:

8.1. Market Snapshot

8.2. Global Nuclear Medicine Diagnostic Market by Procedure, Performance - Potential Analysis

8.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Procedure 2018-2027 (USD Billion)

8.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis

8.4.1. Oncology

8.4.2. Cardiovascular

8.4.3. Central Nervous System

8.4.4. Endocrine

8.4.5. Skeletal

8.4.6. Gastrointestinal

8.4.7. Genito-urinary

8.4.8. Pulmonary

8.4.9. PET & PET-CT

8.4.10. Therapeutics

8.4.11. Others

Chapter 9. Global Nuclear Medicine Diagnostic Market, by End-User:

9.1. Market Snapshot

9.2. Global Nuclear Medicine Diagnostic Market by End-User, Performance - Potential Analysis

9.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)

9.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis

9.4.1. Hospitals and diagnostic centres

9.4.2. Research Institutes

Chapter 10. Global Nuclear Medicine Diagnostic Market, Regional Analysis

10.1. Nuclear Medicine Diagnostic Market, Regional Market Snapshot

10.2. North America Nuclear Medicine Diagnostic Market

10.2.1. U.S. Nuclear Medicine Diagnostic Market

10.2.1.1. Type breakdown estimates & forecasts, 2018-2027

10.2.1.2. Modality breakdown estimates & forecasts, 2018-2027

10.2.1.3. Application breakdown estimates & forecasts, 2018-2027

10.2.2. Canada Nuclear Medicine Diagnostic Market

10.3. Europe Nuclear Medicine Diagnostic Market Snapshot

10.3.1. U.K. Nuclear Medicine Diagnostic Market

10.3.2. Germany Nuclear Medicine Diagnostic Market

10.3.3. France Nuclear Medicine Diagnostic Market

10.3.4. Spain Nuclear Medicine Diagnostic Market

10.3.5. Italy Nuclear Medicine Diagnostic Market

10.3.6. Rest of Europe Nuclear Medicine Diagnostic Market

10.4. Asia-Pacific Nuclear Medicine Diagnostic Market Snapshot

10.4.1. China Nuclear Medicine Diagnostic Market

10.4.2. India Nuclear Medicine Diagnostic Market

10.4.3. Japan Nuclear Medicine Diagnostic Market

10.4.4. Australia Nuclear Medicine Diagnostic Market

10.4.5. South Korea Nuclear Medicine Diagnostic Market

10.4.6. Rest of Asia Pacific Nuclear Medicine Diagnostic Market

10.5. Latin America Nuclear Medicine Diagnostic Market Snapshot

10.5.1. Brazil Nuclear Medicine Diagnostic Market

10.5.2. Mexico Nuclear Medicine Diagnostic Market

10.6. Rest of The World Nuclear Medicine Diagnostic Market

Chapter 11. Competitive Intelligence

11.1. Top Market Strategies

11.2. Company Profiles

11.2.1. AMCS group

11.2.1.1. Key Information

11.2.1.2. Overview

11.2.1.3. Financial (Subject to Data Availability)

11.2.1.4. Product Summary

11.2.1.5. Recent Developments

11.2.2. Caverion corporation

11.2.3. Aerbin ApS

11.2.4. MariMatic Oy

11.2.5. Envac Group

11.2.6. Logiwaste AB

11.2.7. AWC Berhad Gropu

11.2.8. Ros Roca SA

11.2.9. Greenwave Solutions

11.2.10. STREAM environment

Chapter 12. Research Process

12.1. Research Process

12.1.1. Data Mining

12.1.2. Analysis

12.1.3. Market Estimation

12.1.4. Validation

12.1.5. Publishing

12.2. Research Attributes

12.3. Research Assumption

List of Tables

TABLE 1. Global Nuclear Medicine Diagnostic market, report scope

TABLE 2. Global Nuclear Medicine Diagnostic market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Nuclear Medicine Diagnostic market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 4. Global Nuclear Medicine Diagnostic market estimates & forecasts by Modality 2018-2027 (USD Billion)

TABLE 5. Global Nuclear Medicine Diagnostic market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 6. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. Canada Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. UK Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Germany Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. RoE Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. China Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. India Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Japan Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Brazil Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Mexico Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. RoLA Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Row Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Nuclear Medicine Diagnostic market

TABLE 56. List of primary sources, used in the study of global Nuclear Medicine Diagnostic market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
View Details
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research